Scientific Sessions 2024  /  Applying Advances in Risk Prediction to PREVENT CV Disease  /  Case: managing a patient with discordant ASCVD and HF risk
Logo

American Heart Association

  2
  0

Final ID:

Case: managing a patient with discordant ASCVD and HF risk

  • Ostrominski, John  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
    • Author Disclosures:
    John Ostrominski: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Applying Advances in Risk Prediction to PREVENT CV Disease

Monday, 11/18/2024 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Using long term risk estimates to support CVD prevention efforts

Berry Jarett, Magnani Jared

The nuts and bolt of the PREVENT risk model

Khan Sadiya, Coresh Josef

More abstracts from these authors:
Estimating Time to Incidence and Progression of Cardiovascular-Kidney-Metabolic Multimorbidity: A Large-Scale Longitudinal Cohort Study

Ostrominski John, Hirsch Jamie, Miao Benjamin, Clark Brendan, Donato Bonnie Mk, Woolley Jonathan, Parrinello Christina, O'connell Thomas, Vaduganathan Muthiah

The Supplementary Anti-Obesity Medication Integration into a Longitudinal Weight Loss (SAIL) Program: Early Experience in a Remote Comprehensive Weight Management Solution In Patients with CardioMetabolic Risk

Ostrominski John, Blood Alexander, Tucci Michela, Zelle David, Baer Heather, Unlu Ozan, Mccarthy Ashley, Gabovitch Dan, Apovian Caroline, Scirica Benjamin

You have to be authorized to contact abstract author. Please, Login
Not Available